Neto Malinda Trading Ltd. (TLV:NTML)

Theseus Pharmaceuticals Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	38.48	38.54	6.08	8.3	13.46	82.84
Short-Term Investments	-	0.1	0.04	0.02	-	-
Cash & Short-Term Investments	38.48	38.63	6.13	8.31	13.46	82.84
Cash Growth	236.70%	530.40%	-26.27%	-38.25%	-83.75%	326.76%
Accounts Receivable	1,219	1,099	977.43	1,031	931.79	727.76
Other Receivables	38.75	31.91	54.51	33.51	5.16	2.2
Receivables	1,258	1,152	1,058	1,094	965.35	750.7
Inventory	629.49	522.04	493	479.8	449.31	365.45
Prepaid Expenses	-	5.42	5.02	2.13	1.95	1.82
Other Current Assets	-	2.5	0.92	3.63	8.27	1.87
Total Current Assets	1,926	1,720	1,563	1,588	1,438	1,203
Property, Plant & Equipment	248.45	253.37	261.57	236.82	160.29	109.79
Long-Term Investments	90.49	81.86	68.73	66.47	85.47	35.18
Goodwill	-	3.46	3.46	3.46	2.5	-
Other Intangible Assets	11.97	8.73	9.98	10.86	11.56	9.7
Long-Term Deferred Tax Assets	2.6	2.32	2.21	1.46	1.28	3.96
Other Long-Term Assets	5.39	5.36	6.7	7.19	-	0.23
Total Assets	2,285	2,076	1,917	1,916	1,702	1,363
Accounts Payable	436.6	439.99	275.83	219.47	281.08	290.87
Accrued Expenses	8.31	31.85	29.75	29.85	28.66	22.09
Short-Term Debt	180.68	36.04	234.26	368.34	223.29	28.53
Current Portion of Leases	7.93	6.53	6.72	6.78	2.67	1.55
Current Income Taxes Payable	27.58	21.28	0.17	0.25	25.25	13.74
Current Unearned Revenue	-	0.33	0.24	0.08	-	-
Other Current Liabilities	32.35	15.05	6.33	5.35	39.58	4.92
Total Current Liabilities	693.45	551.06	553.3	630.12	600.53	361.71
Long-Term Debt	1.5	1.42	0.85	0.23	-	-
Long-Term Leases	51.44	53.96	62.1	70.05	15.34	10.57
Long-Term Deferred Tax Liabilities	8.33	6.02	3.4	5.13	8.71	1.76
Other Long-Term Liabilities	-	-	-	1.06	0.93	2.17
Total Liabilities	765.91	622.16	630.65	718.29	637.81	386.19
Common Stock	20.88	20.88	20.88	20.88	20.88	20.88
Additional Paid-In Capital	91.75	91.75	91.75	91.75	91.75	204.25
Retained Earnings	1,370	1,316	1,156	1,065	934.28	749.33
Treasury Stock	-9.64	-9.64	-9.64	-9.64	-9.64	-9.64
Comprehensive Income & Other	30.89	22.35	13.5	17.38	18.62	-1.75
Total Common Equity	1,504	1,442	1,272	1,185	1,056	963.06
Minority Interest	15.42	12.19	14.63	12.3	7.84	13.86
Shareholders' Equity	1,519	1,454	1,287	1,197	1,064	976.93
Total Liabilities & Equity	2,285	2,076	1,917	1,916	1,702	1,363
Total Debt	241.55	97.95	303.93	445.4	241.29	40.66
Net Cash (Debt)	-203.07	-59.32	-297.8	-437.09	-202.96	61.99
Net Cash Per Share	-10.26	-3.00	-15.05	-22.09	-10.26	3.13
Filing Date Shares Outstanding	19.79	19.79	19.79	19.79	19.79	19.79
Total Common Shares Outstanding	19.79	19.79	19.79	19.79	19.79	19.79
Working Capital	1,233	1,169	1,010	957.54	837.81	840.97
Book Value Per Share	76.00	72.84	64.28	59.88	53.35	48.66
Tangible Book Value	1,492	1,429	1,259	1,171	1,042	953.36
Tangible Book Value Per Share	75.39	72.23	63.60	59.15	52.64	48.17
Buildings	-	83.84	83.72	82.13	80.41	91.22
Machinery	-	501.5	482.17	457.3	440.95	295.65
Leasehold Improvements	-	80.37	77.5	51.4	33.55	23.36

Source: S&P Global Market Intelligence. Standard template. Financial Sources.